2070 Stock Overview
Develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Saudi Pharmaceutical Industries and Medical Appliances Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س31.15 |
| 52 Week High | ر.س42.85 |
| 52 Week Low | ر.س24.92 |
| Beta | 0.61 |
| 11 Month Change | -0.16% |
| 3 Month Change | -2.50% |
| 1 Year Change | -8.52% |
| 33 Year Change | -19.92% |
| 5 Year Change | 22.40% |
| Change since IPO | 15.08% |
Recent News & Updates
Recent updates
Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump
Sep 05
Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing
Mar 21Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?
Jun 26Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?
Mar 14Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price
Aug 02Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60
May 19One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates
May 12A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Feb 20Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 18Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?
Mar 30Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?
Feb 23What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition
Jan 19
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?
Dec 16Shareholder Returns
| 2070 | SA Pharmaceuticals | SA Market | |
|---|---|---|---|
| 7D | 1.5% | -1.8% | -0.04% |
| 1Y | -8.5% | 8.0% | -9.2% |
Return vs Industry: 2070 underperformed the SA Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: 2070 matched the SA Market which returned -9.2% over the past year.
Price Volatility
| 2070 volatility | |
|---|---|
| 2070 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in SA Market | 7.5% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 2070 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 2070's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Jerome Roger Cabannes | www.spimaco.com.sa |
Saudi Pharmaceutical Industries and Medical Appliances Corporation develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia. The company is also involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics, as well as engages in wholesale and retail of medicines and related products. It operates and maintains healthcare facilities.
Saudi Pharmaceutical Industries and Medical Appliances Corporation Fundamentals Summary
| 2070 fundamental statistics | |
|---|---|
| Market cap | ر.س3.74b |
| Earnings (TTM) | ر.س23.25m |
| Revenue (TTM) | ر.س1.63b |
160.8x
P/E Ratio2.3x
P/S RatioIs 2070 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2070 income statement (TTM) | |
|---|---|
| Revenue | ر.س1.63b |
| Cost of Revenue | ر.س894.55m |
| Gross Profit | ر.س733.41m |
| Other Expenses | ر.س710.17m |
| Earnings | ر.س23.25m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.19 |
| Gross Margin | 45.05% |
| Net Profit Margin | 1.43% |
| Debt/Equity Ratio | 96.0% |
How did 2070 perform over the long term?
See historical performance and comparison